Story · Public Health

HLTH 2026: Noom, Hims & Hers expand into booming peptide market

2 outlets · first reported by Fierce Healthcare on · latest · 25 hours of coverage

Noom and Hims & Hers are making a play for the booming peptide market as the federal government loosens restrictions on compounded treatments. (Fierce Healthcare)

Coverage, in order

  1. first Fierce Healthcare indie
    HLTH 2026: Noom, Hims & Hers expand into booming peptide market

    Noom and Hims & Hers are making a play for the booming peptide market as the federal government loosens restrictions on compounded treatments.

  2. STAT Biotech indie
    STAT+: Peptide market poised to explode with new Hims and Noom launches

    Peptides are poised to go mainstream with this week’s launches from telehealth companies Hims & Hers and Noom, both of which announced they will be offering prescriptions for eligible patients. Synthetic peptides are a broad category of short-chain amino acids. Initially popular among bodybuilders…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.